3 reports of this reaction
3.3% of all ANTACID TABLETS reports
#2 most reported adverse reaction
GAIT DISTURBANCE is the #2 most commonly reported adverse reaction for ANTACID TABLETS, manufactured by Rising Pharma Holdings, Inc.. There are 3 FDA adverse event reports linking ANTACID TABLETS to GAIT DISTURBANCE. This represents approximately 3.3% of all 92 adverse event reports for this drug.
Patients taking ANTACID TABLETS who experience gait disturbance should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
GAIT DISTURBANCE is moderately reported among ANTACID TABLETS users, representing a notable but not dominant share of adverse events.
In addition to gait disturbance, the following adverse reactions have been reported for ANTACID TABLETS:
The following drugs have also been linked to gait disturbance in FDA adverse event reports:
GAIT DISTURBANCE has been reported as an adverse event in 3 FDA reports for ANTACID TABLETS. This does not prove causation, but indicates an association observed in post-market surveillance data.
GAIT DISTURBANCE accounts for approximately 3.3% of all adverse event reports for ANTACID TABLETS, making it one of the most commonly reported side effect.
If you experience gait disturbance while taking ANTACID TABLETS, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.